h-header

news

News dal mondo

27

Gen

Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase

  • lobal pharmaceutical output surged in 2025 due to preemptive production ahead of U.S. tariff actions, with a 9.1% increase in manufacturing output.
  • The pharmaceutical sector benefits from structural resilience, stable demand, and strong credit conditions, supporting long-term investment despite economic uncertainties.....[PharmExec]

21

Apr

TGA clarifies therapeutic goods are unaffected by chemical production and import ban

TGA has clarified the impact of Australia’s industrial chemicals standards on medicines, medical...

20

Apr

US FDA Draft Guidance on Establishing Impurity Specifications for Antibiotics

FDA issued the draft guidance for industry, Establishing Impurity Specifications for Antibiotics. This...

20

Apr

Alfasigma cede a Fine Foods il 100% di Sofar

Alfasigma S.p.A. comunica di aver sottoscritto un accordo per la cessione del 100% del capitale...

17

Apr

Sostanze stupefacenti, il Ministero aggiorna le tabelle: inclusa la classe dei Nitazeni tra le sostanze vietate

È stato pubblicato nella Gazzetta Ufficiale il Decreto ministeriale 2 aprile 2026, con il...

slider-banner

h-footer